Skip to main content

Heparanase

  • Living reference work entry
  • First Online:
  • 96 Accesses

Definition

Heparanase is a mammalian enzyme (endo-β-glucuronidase) degrading heparan sulfate (HS), a ubiquitous strongly anionic linear polysaccharide associated with the cell surface and extracellular matrix (ECM) of a wide range of cells of vertebrate and invertebrate tissues. The enzyme cleaves glycosidic bonds in HS with a hydrolase mechanism and is thus distinct from bacterial eliminases, called heparinase and heparitinase. The heparanase enzyme facilitates cell migration and egress from blood vessels and hence plays a role in tumor metastasis, angiogenesis, inflammation, and autoimmunity. Heparanase activity has been identified in a variety of human tumors (i.e., melanoma; carcinoma of the breast, liver, colon, prostate, and pancreas; myeloid leukemia) and certain normal cells (i.e., cytotrophoblasts, platelets, neutrophils, activated T lymphocytes). HS chains (Mr ∼ 30,000) are cleaved by heparanase at only a few sites, resulting in HS fragments of still appreciable size (Mr ∼...

This is a preview of subscription content, log in via an institution.

References

  • Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38:2018–2039

    Article  CAS  PubMed  Google Scholar 

  • McKenzie EA (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151:1–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parish CR, Freeman C, Hulett MD (2001) Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 1471:M99–M108

    CAS  PubMed  Google Scholar 

  • Pisano C, Vlodavsky I, Ilan N, Zunino F (2014) The potential of heparanase as a therapeutic target in cancer. Biochem Pharmacol 89:12–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanderson RD, Yang Y, Suva LJ, Kelly T (2004) Heparan sulfate proteoglycans and heparanase – partners in osteolytic tumor growth and metastasis. Matrix Biol 23:341–352

    Article  CAS  PubMed  Google Scholar 

  • Vlodavsky I, Ilan N, Naggi A, Casu B (2007) Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13:2057–2073

    Article  CAS  PubMed  Google Scholar 

  • Weissmann M, Arvatz G, Horowitz N, Feld S, Naroditsky I, Zhang Y, Ng M, Hammond E, Nevo E, Vlodavsky I, N. Ilan N (2016) Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proc Natl Acad Sci USA 113:704–709

    Google Scholar 

  • Wu L, Viola CM, Brzozowski AM, Davies GJ (2015) Structural characterization of human heparanase reveals insights into substrate recognition. Nat Struct Mol Biol 22:1016–1022

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Israel Vlodavsky .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Vlodavsky, I. (2015). Heparanase. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_2639-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_2639-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics